Table 1 Percent CD23⁺/CD23^- cells expressing surface molecules or cytokines after exposure of B cells to EBV

CD58

1.5

14.5

59.3

50.9

81.2

30.5

45.6

64.9

57.8

59.3

IL6

0.5

2.5

6.8

13.5

44

0.5

0.2

0.2

1.7

1.3

CD57

1

5.4

15.8

27.3

43.2

9.7

8.2

6.5

10.3

8.3

CD86

17.6

23.2

21.2

35.3

38.5

24.5

23.6

36.7

60.4

63.2

MHC CII

99.9

99.6

99.5

99.7

99.9

72.2

75.1

71.8

74.8

69

PD1

14.2

10.8

8.5

9.1

6

5.6

5.6

4.8

6.1

8.6

IL10

0.2

0.1

0.1

0.07

0.09

0.1

0.08

0.09

0.06

0.1

Subject 2

CD58

1

21.5

22.1

38

45.1

39.9

47.6

57.1

54.3

57.6

IL6

0.6

1.6

2.8

14.5

20.7

0.7

1.6

0.9

0.9

0.4

CD57

1.4

3.5

5.3

8.9

17.7

17.6

18.2

14.9

13.7

12.5

CD86

16.8

17.4

15.9

36.2

48.8

34.3

36.5

51.4

54.5

57.5

MHC CII

99.4

99.1

99.2

99.3

99.7

59.2

57.2

61.7

63.4

63.8

PD1

1.8

1.7

1.1

3.9

5.8

2.3

2.1

1

1.7

2.8

IL10

0.1

0.1

0.1

0.04

0.2

0.03

0.04

0.04

0.05

0.08